GTMB 7 - Gene Therapy & Molecular Biology

George et al: Gene therapy for vascular diseasesStephan D, San H, Yang Z, Gordon D, Goelz, S, Nabel G, NabelE (1997) Inhibiton of vascular smooth muscle cellproliferation and intimal hyperplasia by gene transfer of betainterferon.Mol Med 3, 593-599.Stewart D, investigators o.b.o.ts (2002) A phase 2, randomizedmulticenter 26-week study to assess the efficacy and safetyof BIOBYPASS (AdGVVEGF121.10) delivered throughminimally invasive surgery versus maximum medicaltreatment in patients with severe angina advanced coronaryartery disease and no options for revascularization.Circulation 106, 23-26.Summerford C, Samulski R (1998) Membrane-associatedheparan sulfate proteoglycan is a receptor for adenoassociatedvirus yype 2 virions. J. Virol. 72, 1438-1445.Summerford C, Bartlett J, Samulski R (1999) aVb5 integrin: aco-receptor for adeno-associated virus type 2 infection. NatMed 5, 78-82.Symes J.F, Losordo D, Vale P.R, Lathi K, Esakof D.D, MayskiyM, Isner J (1999) Gene therapy with vascular endothelialgrowth factor for inoperable coronary artery disease. Annalsof Thoracic Surgery 68, 830-836.Tamirisa K.P, Mukherjee D (2002) Gene therapy incardiovascular diseases. Curr Gene Ther. 2:427-435Tang X, Mohuczy, D, Zhang Y.C (1999) Intravenousangiotensinogen antisense in AAV-based vector decreaseshypertension. Am J Physiol 277, H2392-H2399.Taniyama Y, Morishita R, Hiraoka K, Aoki M, Nakagami H,Yamasaki K, Matsumoto K, Nakamura T, Kaneda Y,Ogihara T (2001) Therapeutic angiogenesis induced byhuman hepatocyte growth factor gene in rat diabetic hindlimb ischemia model: molecular mechanisms of delayedangiogenesis in diabetes. Circulation 104, 2344-2350.Taniyama Y, Tachinaba K, Hiroaka K, Namba T, Yamasaki K,Hashiya N, Aoki M, Ogihara T, Yasufumi K, Morishita R(2002) Local delivery of plasmid DNA into rat carotid arteryusing ultrasound. Circulation 105, 1233-1239.Tomko R.P, Xu R, Philipson L (1997) HCAR and MCAR: Thehuman and mouse cellular receptors for subgroup Cadenoviruses and group B coxsackieviruses. Proc Natl AcadSci USA 94, 3352-3356.Tulis DA, Mynjoyan Z, Schiesser R, Shelat H, Evans A,Zoldhelyi P, Fujise K (2003) Adenoviral gene transfer offortilin attenuates neointima formation through suppressionof vascular smooth muscle cell proliferation and migration.Circulation 107, 98-105.Ueno H, Yamamoto H, Ito S.I, Li J, Takeshita A (1997)Adenovirus-mediated transfer of a dominant-negative H-rassuppresses neointimal formation in balloon-injured arteries invivo. Arterioscler Thromb Vasc Biol. 17, 898-904.Van Belle E, Tio F, Chen D, Maillard L, Chen D, Kearney, M,Isner J (1997) Passivation of metallic stents after arterialgene transfer of phVEGF165 inhibits thrombus formationand intimal thickening. J Am Coll Cardiol 29, 1371-1379.Varenne O, Pislaru S, Gillijns H, Van Pelt N, Gerard R.D,Zoldhelyi P, Van de Werf F, Collen D, Janssens S.P (1998)Local adenovirus-mediated transfer of human endothelialnitric oxide synthase reduces luminal narrowing aftercoronary angioplasty in pigs. Circulation 98 (9), 919-926.Vigna E, Cavalieri S, Ailles L, Guena M, Loew, R, Buyjard H,Naldini L (2002) Robust and efficient regulation of transgeneexpression in vivo by improved tetracycline-dependentlentiviral vectors. Mol Ther 5, 252 -257.von der Leyen H.E, Gibbons G, Morishita R, Lewis N, Zhang L,Nakajima M, Kaneda Y, Cooke J, Dzau V (1995) Genetherapy inhibiting neointimal vascular lesion: in vivo transferof endothelial cell nitric oxide synthase gene. Proc NatlAcad Sci USA 92, 1137-1141.Wang C, Chao L, Chao J (1995) Direct gene delivery of humantissue kallikrein reduces blood pressure in spontaneouslyhypertensive rats. J Clin Invest 95, 1710-1716.Wang C, Dobrzynski E, Chao J (2001) Adrenomedullin genedelivery attenuates renal damage and cardiac hypertrophy inGoldblatt hypertensive rats. Am J Physiol Renal Physiol280, F964-F971.Wang H, Katovich, M, Gelband C, Reaves P.Y, Phillips M.I,Raizada M.K (1999) Sustanined inhibition of angiotensin I-converting enzyme (ACE) expression and long-termantihypertensive action by virally mediated delivery of ACEantisense cDNA. Circ Res 85, 614-622.Wang H, Reaves P.Y, Gardon M (2000) Angiotensin I-converting enzyme antisense gene therapy causes permanentantihypertensive effects in the SHR. Hypertension 35, 202-208.Waugh, J, Kattash, M, Li J, Yuksel E, Kuo M.D, Lussier M,Weinfeld A.B, Saxena R, Rabinovsky, E.D, Thung S, WooS.L Shenaq, S (1999a) Gene therapy to promotethromboresistance: local overexpression of tissueplasminogen activator to prevent arterial thrombosis in an invivo rabbit model. Proc Natl Acad Sci USA 96, 1065-1070.Waugh, J, Yuksel E, Li J, Kuo M.D, Kattash, M, Saxena R,Geske R, Thung S.N, Shenaq, S, Woo S (1999b) Localoverexpression of thrombomodulin for in vivo prevention ofarterial thrombosis in a rabbit model. Circ Res 84, 84-92.Wen S, Schneider D, Driscoll R, Vassalli G, Sassani A, Dichek,D (2000) Second-generation adenoviral vectors do notprevent rapid loss of transgene expression amd vector DNAfrom the arterial wall. Arterioscler Thromb Vasc Biol. 20,1452 - 1458.West N, Guzik, T, Black, E, Channon K (2001) Enhancedsuperoxide production in experimental venous bypass graftintimal hyperplasia. Role of NAD (P)H oxidase.Arterioscler Thromb Vasc Biol 21 (189-194).Wickham, T, Mathias P, Cheresh, D, Nemerow, G (1993)Integrins avb3 and avb5 promote adenovirus internalizationbut not virus attachment. Cell 73, 309-319.Wielbo D, Simon A, Phillips M.I (1996) Inhibition ofhypertension by peripheral administration of antisenseoligodeoxynucleotides. Hypertension 28, 147-151.Wolf W Yoshida H, Agata J (2000) Human tissue kallikrein genedelivery attenuates hypertension renal injury, and cardiacremodeling in chronic renal failure. Kidney Int 58, 730-739.Yamamoto K, Morishita R, Tomita N, Shimozato T, NakagamiH, Kikuchi A, Aoki M, Higaki J, Kaneda Y, Ogihara T(2000) Ribozyme oligonucleotides against transforminggrowth factor-b inhibited neointimal formation after vascularinjury in rat model. Circulation 102, 1308-1314.Yang L, Quan S, Abraham, N (1999) Retrovirus-mediated HOgene transfer into endothelial cells protects against osidantinducedinjury. Am J Physiol 277 (1 pt 1), L127-L133.Yang Z, Simari R, ND P, H, S, Gordon D, GJ, N, Nabel E (1996)Role of the p21 cyclin-dependent kinase inhibitor in limitingintimal cell proliferation in response to arterila injury. ProcNatl Acad Sci USA 93 (15), 7905-7910.Yayama K, Wang C, Chao L (1998) Kallikrein gene deliveryattenuates hypertension and cardiac hypertrophy andenhances renal function in Goldblatt hypertensive rats.Hypertension 31, 1104-1110.150